Laboratories are no longer peripheral. They are central to modern clinical development - enabling earlier decision-making, ...

The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...

AI is assisting in trial design aspects such as patient selection and site location Argenica used UK group Brainomix to get its stroke trial program back on track Listed minnow Pathkey AI crunches ...

– KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 –– KPL-387 Phase 1 single ascending dose data support profile for monthly dosing –– Presentation and ...